Received: 22 June 2021
Accepted: 8 December 2021
First Online: 12 January 2022
: The trial was approved by the ethics committee of Iran University of Medical Sciences institutional review board (IR.IUMS.REC.1398.640) and conducted according to the Declaration of Helsinki and subsequent revisions. Written informed consent was obtained from all participants. Patients were informed that their participation was a voluntary activity and that they had the right to leave the study at any time with no negative effect on their treatment. The trial was registered at the Iranian Registry of Clinical Trials on 04/10/2019 (ExternalRef removed; IRCT ID: IRCT20170123032145N4).
: Not applicable
: The authors have no conflicts of interest to report.